Stockreport

Soft Start For $10B-Plus M&A Deals In 2026 [Seeking Alpha]

Boston Scientific Corporation  (BSX) 
Last boston scientific corporation earnings: 4/29 06:30 am Check Earnings Report
US:NYSE Investor Relations: investors.bostonscientific.com
PDF The cash-and-stock deal values Penumbra at $374 per share and will offer $11 billion in cash and roughly $4 billion in Boston Scientific stock, a roughly 73% cash to 27 [Read more]